Newsroom

Arnold Ventures Optimistic Upon Seeing the First Round of Medicare Negotiated Drug Prices Announced
08.15.2024
Arnold Ventures Commends Senate on Unanimous Passage of the Affordable Prescriptions for Patients Act
07.11.2024
Meaningful Reforms Need to be Enacted Sooner Rather Than Later to Protect Medicare Program
05.07.2024
Arnold Ventures Applauds CMS’ Efforts to Rein in Medicare Advantage Costs, Notes 2025 Medicare Rates Include $16 Billion Increase in Plan Payments
04.03.2024
12 Million Vulnerable Seniors Could See Improved Access to Health Care with New Bipartisan Legislation
03.14.2024
What a Bipartisan State of the Union Looks Like
RealClearPolicy 03.04.2024
Statement from Arnold Ventures Executive Vice President of Health Care, Mark E. Miller on the Release of the No Surprises Act IDR Reports
02.16.2024
Hospitals Are Fighting a Medicare Payment Fix That Would Save Tax Dollars
NPR 02.13.2024
Statement from Arnold Ventures Executive Vice President of Health Care, Mark E. Miller on the Additional $16 Billion in Plan Payments in Proposed Medicare Advantage and Part‑D Rate Notice
02.01.2024
Serious Medical Errors Rose After Private Equity Firms Bought Hospitals
The New York Times 12.26.2023
Statement From Arnold Venture’s Mark E. Miller on the U.S. House of Representatives Passage of the Lower Costs, More Transparency Act, a Critical Step Forward in Addressing Rising Health Care Costs
12.12.2023
Health Policy Leaders Launch Coalition to Protect Consumers and Employers from Predatory Health Care Pricing
09.13.2023
Congress Authorizes Overhaul of Troubled Organ Transplant System
The Washington Post 07.28.2023
Hospitals Are in the Hotseat for Their Billing Practices
Axios 07.26.2023
New Law Goes Into Effect to Strengthen The Maryland Prescription Drug Affordability Board
04.11.2023
Statement from Arnold Ventures’ Mark E. Miller on Biden Administration’s Decision to Slow Implementation of Medicare Advantage Reforms
03.31.2023
California Selects Civica Rx as Its Insulin Manufacturing Partner
03.20.2023
New Survey Shows Americans Overwhelmingly Believe Congress and the Administration Should Crack Down on Medicare Advantage Insurers for Abusive Billing Practices
03.20.2023
Statement on the Biden Administration’s Final Regulations to Implement the No Surprises Act
08.19.2022
Statement from Laura and John Arnold on Landmark Law to Lower Prescription Drug Prices
08.16.2022
Statement from Laura and John Arnold Following Senate Passage of the Inflation Reduction Act of 2022
08.07.2022
“It’s time to finish the job.”: Statement from Mark E. Miller on Historic Opportunity for Congress to Lower Prescription Drug Prices
06.30.2022
Statement from Mark E. Miller on Medicare Advantage Oversight Hearing
06.27.2022
Statement from Mark E. Miller on New Insulin Legislation Offered in Senate
06.23.2022

Media Inquiries

If you are a member of the media, contact us via email at media@arnoldventures.org. Please include your name, media outlet affiliation, contact information, questions, and deadline.

What are you looking for?

Our Work About News & Stories Grants Resources Careers Contact Press Releases Employees Newsletter